Filing Details
- Accession Number:
- 0001415889-23-017028
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-12-29 21:05:14
- Reporting Period:
- 2022-09-23
- Accepted Time:
- 2023-12-29 21:05:14
- Original Submission Date:
- 2022-09-26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1711968 | Leonard Steven Chapman | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | Ceo And President | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-09-23 | 1,674 | $45.30 | 71,438 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.9030 to $45.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The prior Form 4 incorrectly reported the number of securities beneficially owned following the reported transaction.